| Similar Articles |
|---|
 |
The Motley Fool
August 19, 2010
Brian Orelli |
Buffett Is Buying J&J. Should You? It depends on your time horizon.   |
The Motley Fool
August 16, 2010
Rick Aristotle Munarriz |
These Schools Are Getting Schooled Weak student loan repayments are crushing post-secondary educators. |
The Motley Fool
March 24, 2011
Anand Chokkavelu |
Rising Star Buy: Johnson & Johnson It's time to buy shares of Johnson & Johnson, the "health-care mutual fund." |
The Motley Fool
August 24, 2010
Matt Koppenheffer |
How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale? |
The Motley Fool
September 24, 2010
Anand Chokkavelu |
10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list |
The Motley Fool
September 16, 2010
Jordan DiPietro |
Are These Stocks Finally Cheap Enough? Has all the bad news been baked into for-profit educators? |
The Motley Fool
August 17, 2010
April Taylor |
Buffett Buys: A New Stock and Doubling Down on J&J Berkshire Hathaway's Warren Buffett was back in buying mode during the second quarter; the big moves were the addition to Berkshire's stake in Johnson & Johnson and establishment of a new position in Fiserv. |
The Motley Fool
September 28, 2009
Brian Orelli |
The Berkshire of Health Care Johnson & Johnson is becoming the Berkshire Hathaway of health care. In addition to its usual M.O. of bolt-on acquisitions, the health-care giant has recently taken some equity stakes in smaller drug companies. |
BusinessWeek
September 2, 2010
Greg Bensinger |
Student Loan Scrutiny Could Hurt Washington Post The Washington Post's Kaplan education unit may be battered by a crackdown on loan repayment rules. |
The Motley Fool
June 2, 2011
Cindy Johnson |
For-Profit Education Company Shares Popped: What You Need to Know For-profit education companies popped after the Department of Education released new regulations that were not as harsh as the draft version. |
The Motley Fool
May 31, 2007
Ryan Fuhrmann |
Dueling Fools: Eli Lilly Bull Rebuttal Investors need to keep looking for further proof that Lilly's valuation premium to its peers is fully warranted, but if current trends are any indication, its growth prognosis could lead the industry. |
The Motley Fool
November 22, 2006
Steven Mallas |
Dueling Fools: Johnson & Johnson Bull Rebuttal Plenty of opportunities lie ahead for Johnson & Johnson, and even in down times, you've got a good defensive stock. |
The Motley Fool
August 12, 2011
David Williamson |
What Happened to U.S. Pharma? How did the domestic pharmaceutical industry fare in the most recent quarter? |
The Motley Fool
February 18, 2011
Brian Stoffel |
Why I'm Staying Away From For-Profit Education. There are a number of forces working against the industry. |
The Motley Fool
August 24, 2010
Brian Orelli |
One Day, the J&J Recalls Will End Just not today. Johnson & Johnson's consumer health segment gets more than half of its sales from outside the U.S., so tainting its image outside the U.S. could be costly as well. |
The Motley Fool
December 4, 2008
Brian Orelli |
Drug Deals Require Cash Pharmaceutical companies have been hoarding cash -- patiently waiting for good prices. And it looks like that time has arrived. Take a look at some players in the pharmaceutical field. |
The Motley Fool
August 27, 2010
Eben Esterhuizen |
Warren Buffett's Trades: Visualizing the Oracle's Portfolio Tweaks A look at Berkshire Hathaway's recent moves. |
The Motley Fool
December 31, 2007
Brian Orelli |
Best Stock for 2008: Johnson & Johnson Down on its luck for 2007, here's why Johnson & Johnson's stock will rebound in 2008. |
The Motley Fool
October 17, 2006
Brian Lawler |
See Johnson & Johnson Crawl Earnings growth isn't moving right along because the company has become so big. Investors, take note. |
The Motley Fool
January 20, 2011
April Taylor |
ITT's Solid Quarter and Cloudy Future Will ITT Educational's new enrollments surprise or disappoint in 2011? |
The Motley Fool
January 12, 2011
April Taylor |
For-Profit Education Stocks -- Not as Cheap as They Look These stocks have taken a pounding. |
The Motley Fool
January 26, 2011
Brian Orelli |
J&J Will Recover -- Someday Consumer health care might be the smallest of Johnson & Johnson's three divisions, but the 15% drop in revenue still hurts. A lot. |
The Motley Fool
January 8, 2008
Mac Greer |
Fool Video: The Best Stock for 2008, Buffett's Latest, and Bear Market Buys Can Apple continue to produce? Will McDonald's serve up big earnings? Is 2008 the year for Johnson & Johnson? Will Starbucks continue to yield not-so-grande returns? These and other questions are answered in this video. |
The Motley Fool
October 14, 2010
Brian D. Pacampara |
For-Profit Educators Plunged: What You Need to Know Is this meaningful? Or just another movement? |
The Motley Fool
June 2, 2011
Brian Stoffel |
This Government Rule Should Make You Irate The gainful employment rules are a far cry from what they were before the for-profit education industry sent their lobbyists to Washington. |
The Motley Fool
January 28, 2011
Anand Chokkavelu |
10 Core Stocks: A Johnson & Johnson Update The steady reliability of J&J stock will comfort the core of your portfolio when the market gets a boo-boo. |
The Motley Fool
October 20, 2011
Brian Stoffel |
An Entire Industry in Denial For-profit schools don't add enough value to students' prospects to justify the tuition. However virtuous their stated intentions, all too often schools simply saddle disadvantaged students with more debt that they could ever handle. |
The Motley Fool
August 18, 2009
Morgan Housel |
Warren Buffett Goes Buying ... and Selling Warren Buffett's moves over the years would leave you well ahead of the pack. Here's a rundown of Berkshire's latest buys and sells. |
The Motley Fool
January 13, 2012
Morgan Housel |
5 Companies You Can Buy Today Cheap by the numbers. |
The Motley Fool
July 20, 2010
Brian Orelli |
Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant. |
The Motley Fool
July 27, 2009
Selena Maranjian |
Let Me Save You $1.7 Million Let me offer you some of Buffett's food for thought -- even if it comes without the million-dollar meal he auctions off for charity. |
The Motley Fool
January 18, 2011
Russ Krull |
Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold? |
The Motley Fool
September 17, 2010
James Early |
Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care. |
The Motley Fool
June 30, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Major Wall Street investment house Soleil Securities downgraded Eli Lilly shares to "sell." |
The Motley Fool
January 12, 2011
Gary Cassady |
Before You Invest in For-Profit Education Double-digit dives in new student enrollment sent for-profit education stocks tumbling on Monday. |
The Motley Fool
August 18, 2010
Seth Jayson |
How to Go Broke in the Market Don't be scammed by the bozos who spam your email with faux stock tips, touting tiny, mostly revenue-less wonders as the next big thing. |
The Motley Fool
September 30, 2010
Brian Orelli |
Chief Justice Roberts Sold Pfizer. Should You? Maybe, but not for the same reason. |
The Motley Fool
August 28, 2010
Todd Wenning |
Dividend Report Card: Johnson & Johnson Does this health-care titan's dividend pass the test? |
The Motley Fool
November 26, 2007
Brian Orelli |
Johnson & Johnson Reorganizes -- Who Wins? Johnson & Johnson announces the second phase of its reorganization plan. While it may take years to see whether the measures will help J&J, some other companies could benefit far more quickly. |
The Motley Fool
May 28, 2009
Liz Peek |
Will Uncle Sam Change For-Profit Schools' Rules? For-profit educators could face greater government intervention. |
The Motley Fool
May 18, 2009
Morgan Housel |
Warren Buffett Goes Shopping Berkshire's latest quarterly filing shows substantial purchases in two of his favorite banks: Wells Fargo and US Bancorp, consumer products maker Johnson & Johnson, and a sale of ConocoPhillips. |
The Motley Fool
March 11, 2009
Matt Koppenheffer |
Market Bottoms Don't Happen Mid-Week It's not likely that market experts will give up on trying to figure out the best day for a market bottom, but most investors will do best spending their time trying to find the best businesses out there. |
The Motley Fool
October 12, 2007
Billy Fisher |
Dueling Fools: Johnson & Johnson Bear Rebuttal The bears say that J&J is a good company, but will underperform looking forward. |
The Motley Fool
June 15, 2006
Selena Maranjian |
My Dividends Are Bigger Than Yours Your yield may be 2% when mine is a whopping 13%. Here's the secret. |
The Motley Fool
November 30, 2011
Brian Orelli |
3 Things More Important to Pfizer Than Losing Lipitor It's not like we didn't see it coming. |
The Motley Fool
January 20, 2006
Selena Maranjian |
Financial Aid to Be Slashed If you're a college student, a prospective college student, or the parent of some such person, take note: Congress is looking to pass the largest cut in student financial aid in American history. But college can still be affordable -- if you plan ahead now. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Bristol-Myers Squibb Look Like a Winning Investment? Bristol-Myers, Pfizer, and J&J all look tempting, trading in the mid-teens relative to their earnings. |
The Motley Fool
October 21, 2011
Alex Pape |
3 Stocks I Own and Would Happily Buy Today These three are worth your consideration: Bridgepoint Education... Berkshire Hathaway... Retail Opportunity Investments... |
The Motley Fool
May 28, 2011
Katie Spence |
Are These Smarties Headed for Disaster? For-profit education gets an F! If Congress does cut funding, it'll result in reduced student populations and an increase in operating costs. |
The Motley Fool
May 12, 2011
Brian Stoffel |
Are These Education Stocks About to Fail? Dig deeper to see how these schools are funded. |
